Health
COVID-19 Vaccine News: Moderna Variant Vaccine Begins Human Testing, AZ Put on Hold in Denmark – BioSpace
Patients in a Phase II trial have begun receiving Moderna’s vaccine against the SARS-CoV-2 variant first identified in South Africa, the company announced.
Patients in a Phase II trial have begun receiving Modernas vaccine against the SARS-CoV-2 variant first identified in South Africa, the company announced. The modified vaccine, mRNA-1273.351, is being tested out of an abundance of caution, despite the fact that previous data has shown that the companys marketed mRNA-1273 vaccine produces neutralizing titers against all relevant variations, the company said.
Similarly inspired by caution, Denmark announced it is temporarilystopping vaccinations with…
-
Business17 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
Noosa News15 hours agoQueensland government to set up $400m energy investment fund
-
Business11 hours agoAustralian rare earths companies trading at record levels as China tightens export controls
-
Business9 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?